Finance

Beta
Lists
LIPO:OTCMKTS
Lipella Pharmaceuticals Inc
$0.10
+31.25%
(+0.025) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LIPO...
Open
$0.08
High
$0.12
Low
$0.08
Mkt. cap
485.19K
Avg. vol.
33.32K
Volume
128.26K
52-wk high
$3.10
52-wk low
$0.02
EPS
-$2.41
Beta
1.80
Shares outstanding
4.62M
No. of employees
5
Open
$0.08
High
$0.12
Low
$0.08
Mkt. cap
485.19K
Avg. vol.
33.32K
Volume
128.26K
52-wk high
$3.10
52-wk low
$0.02
EPS
-$2.41
Beta
1.80
Shares outstanding
4.62M
No. of employees
5
News stories
From sources across the web
About Lipella Pharmaceuticals Inc
CEO-
Employees5
Founded2005
HeadquartersPittsburgh, Pennsylvania, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
173.67K
129.39K
86.73K
-
Cost of goods sold
1.06M
993.48K
791.58K
720.97K
Cost of revenue
1.06M
993.48K
791.58K
720.97K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
562.62K
463.74K
651.72K
553.30K
Operating expense
562.62K
463.74K
651.72K
553.30K
Total operating expenses
1.62M
1.46M
1.44M
1.27M
Operating income
-1.45M
-1.33M
-1.36M
-1.27M
Other non operating income
-
-
-
-
EBT including unusual items
-1.44M
-1.31M
-1.33M
-1.25M
EBT excluding unusual items
-1.44M
-1.31M
-1.33M
-1.25M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.44M
-1.31M
-1.33M
-1.25M
Net profit margin
-830.14%
-1,009.76%
-1,530.65%
-
Earnings per share
-
-
-
-
Interest and investment income
9.62K
21.30K
29.09K
20.19K
Interest expense
-
-
-
-
Net interest expenses
9.62K
21.30K
29.09K
20.19K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.45M
-1.33M
-1.36M
-1.27M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more